Ultrasound-Guided Foam Sclerotherapy (UGFS) for varicose veins
Record ID 32012000172
English
Authors' recommendations:
Varicose veins are enlarged and tortuous vessels that develop when the thin flaps of the venous valves no longer meet in the midline, allowing blood to reflux, or flow in a retrograde direction. Approximately 80 million Americans are affected by some form of venous disorder, including varicose veins. Women are more likely to suffer from varicose veins than men, with as many as 50% of American women affected. Great saphenous vein (GSV) reflux is most commonly responsible for the development of varicose veins. Treatments for symptomatic varicose veins of the legs include conservative measures such as compression hosiery, elevating the legs, walking, and weight management. In cases with severe discomfort, ulceration, or thrombosis, minimally invasive procedures (sclerotherapy, endovenous laser ablation [EVLA], radiofrequency ablation [RFA]) or surgical ligation and excision (vein stripping) may be used to destroy or remove affected vessels.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=13063
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Sclerotherapy
- Varicose Veins
- Ultrasonography, Interventional
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2011 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.